Parties Brief Federal Circuit In Dispute Over Gene Modification Patent
WASHINGTON, D.C. — In an Oct. 25 appellee brief filed with the Federal Circuit U.S. Court of Appeals, a genomic research center argued that an appeal of a Patent Trial and...To view the full article, register now.
Already a subscriber? Click here to view full article